Filing Details

Accession Number:
0001104659-21-067155
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-05-14 21:46:36
Reporting Period:
2021-05-11
Accepted Time:
2021-05-14 21:46:36
Original Submission Date:
2021-05-11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1136174 Ontrak Inc. OTRK () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
904534 S Terren Peizer 2120 Colorado Avenue, #230
Santa Monica CA 90404
Executive Chairman Yes Yes Yes No
1797168 Acuitas Group Holdings, Llc 2120 Colorado Avenue, #230
Santa Monica CA 90404
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-10 498,927 $4.80 9,710,512 No 4 X Indirect By Acuitas
Common Stock Disposition 2021-05-11 1,099 $28.71 9,709,413 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-11 3,401 $29.47 9,706,012 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-11 2,089 $30.58 9,703,923 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-11 2,700 $31.63 9,701,223 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-11 1,711 $32.22 9,699,512 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-12 6,500 $31.27 9,693,012 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-12 4,500 $31.96 9,688,512 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-13 6,629 $29.92 9,681,883 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-13 1,271 $31.07 9,680,612 No 4 S Indirect By Acuitas
Common Stock Disposition 2021-05-13 3,100 $31.93 9,677,512 No 4 S Indirect By Acuitas
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
No 4 S Indirect By Acuitas
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to Purchase Disposition 2021-05-10 498,927 $0.00 498,927 $4.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-08-15 2021-08-15 No 4 X Indirect
Footnotes
  1. This Form 4 is jointly filed by Terren S. Peizer ("Mr. Peizer") and Acuitas Group Holdings, LLC ("Acuitas"). Mr. Peizer is the Chairman and sole member of Acuitas and, in such capacity, exercises voting and investment power over any securities held for the accounts of Acuitas.
  2. On May 11, 2021, the Reporting Persons filed a Form 4 (the "May 11 Form 4") which incorrectly reported, due to a clerical error, that on May 10, 2021, Acuitas exercised, on a cashless basis, a warrant to purchase 498,297 shares of the issuer's common stock for $4.80 per share. In fact, as reported in this Form 4, on May 10, 2021, Acuitas exercised, on a cashless basis, a warrant to purchase 498,927 shares of the issuer's common stock (rather than 498,297 shares) for $4.80 per share.
  3. This Form 4 also corrects the total number of shares of the issuer's common stock beneficially owned by the Reporting Persons following the exercise of all warrants reported on the May 11 Form 4 (net of the issuer's withholding of an aggregate of 89,572 shares in respect of the exercise prices for such warrants), which was incorrectly reported on the May 11 Form 4 as 9,709,882 shares. In fact, as reported in this Form 4, following the exercise of all such warrants on May 10, 2021 (and after giving effect to the issuer's withholding of shares in respect of the exercise prices for such warrants), the Reporting Persons beneficially owned an aggregate of 9,710,512 shares of the issuer's common stock.
  4. Represents sales effected pursuant to a Rule 10b5-1 trading plan entered into by Acuitas on May 10, 2021. The shares sold pursuant to such sales were acquired by Acuitas pursuant to the exercise of warrants held by Acuitas on May 10, 2021, which warrants were set to expire on August 15, 2021 and August 30, 2021.
  5. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $28.090 to $29.070, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $29.120 to $30.050, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.130 to $31.000, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.220 to $32.080, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $32.120 to $32.290, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.710 to $31.660, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.710 to $32.490, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $29.510 to $30.500, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $30.690 to $31.460, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  14. The price reported is a volume weighted average price. The shares were sold in multiple transactions at prices ranging from $31.530 to $32.335, inclusive. The Reporting Persons undertake to provide the issuer, any security holder of the issuer, and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.